BioPerfectus Welcomes Anglophone African Health Delegation to Advance Infectious Disease Diagnostic Collaboration BioPerfectus welcomed a health delegation from the Training Program on Infectious Disease Prevention and Control for Anglophone African Countries to its facility in Jiangsu, China. The visit focused on infectious disease prevention and control, malaria diagnostics, automated molecular testing, rapid testing solutions, and localized IVD applications in African healthcare settings. Through facility tours and technical exchanges, BioPerfectus shared its integrated capabilities in instruments, reagents, manufacturing, and diagnostic solutions to support infectious disease surveillance, outbreak response, and public health capacity building.
As the Northern Hemisphere Mosquito Season Begins, a "Triple Threat" Is Taking Shape Dengue, chikungunya, and Zika share one vector and nearly identical early symptoms — but require very different responses. Here's what the 2025–2026 data tells us, and why precise differentiation matters more than ever.
Beyond the Microscope: The 4 Radical Trends Shifting the Future of Infectious Disease Diagnostics Four macro trends redefining how infectious diseases are diagnosed, treated, and monitored worldwide. The dust has settled in Munich following one of the most pivotal annual gatherings for clinical microbiology and infectious diseases. While the halls of the convention center have emptied, the echoes of the technological breakthroughs showcased there are just beginning to reshape the healthcare landscape. For years, the diagnostics industry operated on a predictable trajectory: one patient, one suspected pathogen, one test. But global health shifts—accelerated by climate change, skyrocketing antimicrobial resistance (AMR), and the urgent need to reduce hospital turnaround times—have reshaped that traditional paradigm. Here are four macro trends coming out of the exhibition that are redefining how we diagnose, treat, and monitor infectious diseases worldwide.
Navigating WHA79: Decoding the Global Health Agenda for Long-Term IVD Strategy The 79th World Health Assembly (WHA79), convening in Geneva in May 2026, marks a pivotal transition in global health governance. Moving past the initial reactive phase of the post-pandemic era, international health policies are now shifting toward structural entrenchment. For the In Vitro Diagnostics (IVD) sector, policy is no longer just a regulatory hurdle—it is a market creator.
The Health Economics of Global HPV Screening: A Blueprint for the 2030 Elimination Goals As the world unites around International Women’s Health Day on May 18, the WHO’s 2030 strategy to eliminate cervical cancer stands as both a moral mission and one of the most compelling economic growth strategies of the decade.
BioPerfectus Influenza A Virus (H1N1 & H3) Real Time PCR Kit Receives NMPA Approval Recently, the BioPerfectus Influenza A Virus (H1N1 & H3) Real Time PCR Kit received approval from China’s National Medical Products Administration (NMPA).
Preparing for the 2026 Respiratory Virus Season in the Southern Hemisphere - Two Tests Facing South American Laboratories As the Southern Hemisphere transitions into autumn and winter, the 2026 respiratory virus season arrives carrying two parallel challenges.
World Malaria Day 2026: Driven to End Malaria — Now We Can. Now We Must. April 25 marks World Malaria Day 2026. Explore the latest WHO data, global progress, remaining challenges, and what it takes to end malaria for good
A New Year Message from the Chairman & CEO of BioPerfectus As the year draws to a close and the Lunar New Year approaches, we stand once again at a moment of renewal. The idea of a “new year” carries a quiet but powerful meaning—no matter what the past has held, it invites us to reset our focus, regain momentum, and move forward with clarity and confidence.
BioPerfectus Empowers Mongolia's National Laboratory to Protect Public Health BioPerfectus collaborates with Mongolia’s National Center of Communicable Diseases to strengthen infectious disease surveillance through reliable molecular diagnostic PCR assays, supporting rapid public-health response.
